136 related articles for article (PubMed ID: 20160682)
1. Comparison of a 3-D multi-group SN particle transport code with Monte Carlo for intracavitary brachytherapy of the cervix uteri.
Gifford KA; Wareing TA; Failla G; Horton JL; Eifel PJ; Mourtada F
J Appl Clin Med Phys; 2009 Dec; 11(1):3103. PubMed ID: 20160682
[TBL] [Abstract][Full Text] [Related]
2. HDRMC, an accelerated Monte Carlo dose calculator for high dose rate brachytherapy with CT-compatible applicators.
Chibani O; C-M Ma C
Med Phys; 2014 May; 41(5):051712. PubMed ID: 24784378
[TBL] [Abstract][Full Text] [Related]
3. Comparison between CT-based volumetric calculations and ICRU reference-point estimates of radiation doses delivered to bladder and rectum during intracavitary radiotherapy for cervical cancer.
Pelloski CE; Palmer M; Chronowski GM; Jhingran A; Horton J; Eifel PJ
Int J Radiat Oncol Biol Phys; 2005 May; 62(1):131-7. PubMed ID: 15850913
[TBL] [Abstract][Full Text] [Related]
4. CT based 3-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: comparison between dose-volume histograms and ICRU point doses to the rectum and bladder.
Hashim N; Jamalludin Z; Ung NM; Ho GF; Malik RA; Phua VC
Asian Pac J Cancer Prev; 2014; 15(13):5259-64. PubMed ID: 25040985
[TBL] [Abstract][Full Text] [Related]
5. Point vs. volumetric bladder and rectal doses in combined intracavitary-interstitial high-dose-rate brachytherapy: correlation and comparison with published Vienna applicator data.
Yaparpalvi R; Mutyala S; Gorla GR; Butler J; Mah D; Garg MK; Kalnicki S
Brachytherapy; 2008; 7(4):336-42. PubMed ID: 18782683
[TBL] [Abstract][Full Text] [Related]
6. Optimization of deterministic transport parameters for the calculation of the dose distribution around a high dose-rate 192Ir brachytherapy source.
Gifford KA; Price MJ; Horton JL; Wareing TA; Mourtada F
Med Phys; 2008 Jun; 35(6):2279-85. PubMed ID: 18649459
[TBL] [Abstract][Full Text] [Related]
7. Monte Carlo model for a prototype CT-compatible, anatomically adaptive, shielded intracavitary brachytherapy applicator for the treatment of cervical cancer.
Price MJ; Gifford KA; Horton JL; Eifel PJ; Gillin MT; Lawyer AA; Mourtada F
Med Phys; 2009 Sep; 36(9):4147-55. PubMed ID: 19810488
[TBL] [Abstract][Full Text] [Related]
8. Monte Carlo dose calculations for a new ovoid shield system for carcinoma of the uterine cervix.
Weeks KJ
Med Phys; 1998 Dec; 25(12):2288-92. PubMed ID: 9874820
[TBL] [Abstract][Full Text] [Related]
9. Image-guided intracavitary high-dose-rate brachytherapy for cervix cancer: A single institutional experience with three-dimensional CT-based planning.
Wang B; Kwon A; Zhu Y; Yeo I; Henson CF
Brachytherapy; 2009; 8(2):240-247. PubMed ID: 19230789
[TBL] [Abstract][Full Text] [Related]
10. Image-based three-dimensional treatment planning of intracavitary brachytherapy for cancer of the cervix: dose-volume histograms of the bladder, rectum, sigmoid colon, and small bowel.
Kim RY; Shen S; Duan J
Brachytherapy; 2007; 6(3):187-94. PubMed ID: 17606413
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Monte Carlo calculations around a Fletcher Suit Delclos ovoid with radiochromic film and normoxic polymer gel dosimetry.
Gifford KA; Horton JL; Jackson EF; Steger TR; Heard MP; Mourtada F; Lawyer AA; Ibbott GS
Med Phys; 2005 Jul; 32(7):2288-94. PubMed ID: 16121584
[TBL] [Abstract][Full Text] [Related]
12. Accurate localization of intracavitary brachytherapy applicators from 3D CT imaging studies.
Lerma FA; Williamson JF
Med Phys; 2002 Mar; 29(3):325-33. PubMed ID: 11929015
[TBL] [Abstract][Full Text] [Related]
13. Sensitivity of low energy brachytherapy Monte Carlo dose calculations to uncertainties in human tissue composition.
Landry G; Reniers B; Murrer L; Lutgens L; Gurp EB; Pignol JP; Keller B; Beaulieu L; Verhaegen F
Med Phys; 2010 Oct; 37(10):5188-98. PubMed ID: 21089752
[TBL] [Abstract][Full Text] [Related]
14. Comparison of conventional and CT-based planning for intracavitary brachytherapy for cervical cancer: target volume coverage and organs at risk doses.
Onal C; Arslan G; Topkan E; Pehlivan B; Yavuz M; Oymak E; Yavuz A
J Exp Clin Cancer Res; 2009 Jul; 28(1):95. PubMed ID: 19570212
[TBL] [Abstract][Full Text] [Related]
15. Comparison between DVH-based doses and ICRU point-based doses to the rectum and the bladder using CT-based high-dose rate brachytherapy to the cervix.
Rangarajan R; Subramanian S; Gopalakrishnan K
Med Dosim; 2018 Autumn; 43(3):276-283. PubMed ID: 29198390
[TBL] [Abstract][Full Text] [Related]
16. Comparison of 2D vs. 3D dosimetry for Rotte 'Y' applicator high dose rate brachytherapy for medically inoperable endometrial cancer.
Beriwal S; Kim H; Heron DE; Selvaraj R
Technol Cancer Res Treat; 2006 Oct; 5(5):521-7. PubMed ID: 16981795
[TBL] [Abstract][Full Text] [Related]
17. Megavoltage computed tomography image-based low-dose rate intracavitary brachytherapy planning for cervical carcinoma.
Wagner TH; Langen KM; Meeks SL; Willoughby TR; Zeidan OA; Staton RJ; Shah AP; Manon RR; Kupelian PA
Technol Cancer Res Treat; 2009 Apr; 8(2):123-30. PubMed ID: 19334793
[TBL] [Abstract][Full Text] [Related]
18. 3D CT-based volumetric dose assessment of 2D plans using GEC-ESTRO guidelines for cervical cancer brachytherapy.
Gao M; Albuquerque K; Chi A; Rusu I
Brachytherapy; 2010; 9(1):55-60. PubMed ID: 19853536
[TBL] [Abstract][Full Text] [Related]
19. Determination of spatial dose distribution in UCC treatments with LDR brachytherapy using Monte Carlo methods.
Benites-Rengifo JL; Vega-Carrillo HR
Appl Radiat Isot; 2018 Nov; 141():224-227. PubMed ID: 29789200
[TBL] [Abstract][Full Text] [Related]
20. Monte Carlo calculations of the dose distribution around a commercial gynecologic tandem applicator.
Gifford KA; Mourtada F; Cho SH; Lawyer A; Horton JL
Radiother Oncol; 2005 Nov; 77(2):210-5. PubMed ID: 16216363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
